| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.5M | +33.5% |
| R&D Expense | $59.8M | +33.1% |
| SG&A Expense | $20.4M | +47.2% |
| Operating Income | -$66.6M | -37.0% |
| Interest Expense | $1.2M | — |
| Net Income | -$66.2M | -36.2% |
| EPS (Basic) | -$2.75 | +34.1% |
| EPS (Diluted) | -$2.75 | +34.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.0M | -25.6% |
| Current Assets | $124.1M | -25.1% |
| Total Assets | $199.1M | +5.8% |
| Current Liabilities | $17.3M | -18.9% |
| Long-term Debt | $29.3M | — |
| Total Liabilities | $99.7M | +264.7% |
| Stockholders' Equity | $99.4M | -38.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.5M | -36.6% |
| Capital Expenditures | $4.2M | -57.5% |
| Investing Cash Flow | -$4.2M | +57.5% |
| Financing Cash Flow | $29.4M | -84.5% |
| Free Cash Flow | -$70.7M | -20.7% |